Rj. Wilkinson et al., EVALUATION OF THE RECOMBINANT 38-KILODALTON ANTIGEN OF MYCOBACTERIUM-TUBERCULOSIS AS A POTENTIAL IMMUNODIAGNOSTIC REAGENT, Journal of clinical microbiology, 35(3), 1997, pp. 553-557
The diagnosis of infection caused by Mycobacterium tuberculosis is of
increased public health concern following increases in the number of c
ases in developed countries and major increases in developing countrie
s associated with the spread of human immunodeficiency virus (HIV) inf
ection. The specificity of purified protein derivative skin testing fo
r the detection of infection is compromised by exposure to environment
al mycobacteria. Examination of sputum detects the most infectious pat
ients, but not those with extrapulmonary disease. The 38-kDa antigen o
f M. tuberculosis contains two M. tuberculosis-specific B-cell epitope
s. We overexpressed the gene for this antigen in Escherichia coli and
evaluated the recombinant product in in vitro assays of T-cell functio
n and as a target for the antibody response in humans. The sensitivity
and specificity of the antigen as a skin test reagent were also asses
sed in outbred guinea pigs. We found that 69% of healthy sensitized hu
mans recognize the antigen in vitro, as manifested by both cell prolif
eration and the production of gamma interferon. Untreated patients ini
tially have a lower frequency of response (38%); this recovers to 72%
during therapy. A total of 292 patients (20 with HIV coinfection) and
58 controls were examined for production of antibody to the 38-kDa ant
igen by using a commercially available kit. The sensitivity of the tes
t in comparison with that of culture was 72.6%, and the specificity wa
s 94.9%. The antigen was also tested for its ability to induce skin re
actions in outbred guinea pigs sensitized by various mycobacterial spe
cies. The antigen provoked significant skin reactions in M. tuberculos
is-, M. bovis BCG-, and M. intracellulare-sensitized animals. The sign
ificance of these findings and the usefulness of this antigen in immun
odiagnosis are discussed.